Clinical Cases in Eye Care

 

Description:

 Clinical Cases in Eye Care provides real-world case examples to illustrate the current scope of primary eye care practice. Over 120 clinical cases help readers gain familiarity with frequently seen scenarios as they would unfold in a typical setting. This case collection is a useful teaching and learning tool for instructors, students and clinicians.

 

Table of Contents:

 

Section 1: Refraction, Perceptual and Binocular Vision

1.1 Astigmatism

Clinical Findings

Comments

Discussion

References

1.2 Presbyopia

Clinical Findings

Discussion

References

1.3 Anisometropia

Clinical Findings

Follow-up Visit (2 Months After the Initial Examination)

Subsequent Follow-up Visits

Discussion

Anisometropic Refractive Errors Associated With Amblyopia

References

1.4 Pseudophakia

Clinical Findings

Discussion

References

1.5 Myopia Control

Clinical Findings

Six-Month Follow-up

Summary

References

1.6 Sports Vision: Lens Tints

Clinical Findings

Supplementary Testing

Using the M&S Sports Performance Software (M&S Technologies, Niles, Illinois)

Using the Senaptec Sensory Performance Software (Synaptec, Beaverton, Oregon)

Discussion

References

1.7 Dispensing Issues With Progressive Addition Lenses: Adaptational Issues When Switching From Conventional to Free-Form Progressive Addition Lenses

Clinical Findings

Comments

Discussion

References

1.8 Dispensing Anomalies: Disorientation Following Prescription Change

Clinical Findings

Comments

Follow-up Visit (1 Month Following Initial Examination)

Follow-up Visit (2.5 Months Following Initial Examination)

Follow-up Visit (3.5 Months Following Initial Examination)

Discussion

References

1.9 Dispensing Issues With Progressive Addition Lenses: Adaptation Issues

Clinical Findings

Comments

Discussion

References

1.10 Prescribing for Musicians

Clinical Findings

Comments

Discussion

References

1.11 Prescribing for a Computer User

Clinical Findings

Comments

Discussion

References

1.12 Eye Protection

Clinical Findings

Discussion

References

1.13 Low Vision Management of a Patient With Choroideremia

Clinical Findings

Low Vision Device Trials

Assessment and Plan

Summary and Conclusions

References

1.14 Age-Related Macular Degeneration

Clinical Findings

Discussion

Age-Related Macular Degeneration

Prognosis

References

1.15 Oculocutaneous Albinism: Low Vision Case Using Simple Magnification

Clinical Findings

Discussion

References

1.16 Use of a Bioptic Telescope for Driving

Clinical Findings

Follow-up Visits

Supplementary Testing: Driver Training With the Certified Driving Rehabilitation Specialist

Additional Follow-up

Discussion

References

1.17 Management of the Geriatric Patient

Clinical Findings

Discussion

References

1.18 A Complex Case of Accommodative Insufficiency

Clinical Findings

Discussion

References

1.19 Convergence Excess

Clinical Findings

Comments

Discussion

References

1.20 Convergence Insufficiency

Clinical Findings

Comments

Vision Skills Evaluation

Discussion

References

1.21 Divergence Excess

Clinical Findings

Comments

Discussion

References

1.22 Clinical Use of Fixation Disparity

Clinical Findings

Comments

Discussion

References

1.23 Vision Therapy in an Adult With Congenital Nystagmus

Clinical Findings

Discussion

References

1.24 Management of Convergence Insufficiency With Prism

Clinical Findings

Comments

Discussion

References

1.25 Vertical Heterophoria

Clinical Findings

Comments

Discussion

References

1.26 Amblyopia

Clinical Findings

Comments

Follow-up Visits

Comments

Other Considerations

Discussion

References

1.27 Neuro-Optometric Rehabilitation of a Post-concussion Patient

Clinical Findings

Discussion

Phase 1: Visual Stabilization

Phase 2: Binocular Visual Integration

Phase 3: Visual Automaticity

Outcomes

References

1.28 Intermittent Exotropia, Divergence Excess Type

Clinical Findings

Discussion

References

1.29 Duane Retraction Syndrome

Clinical Findings

Comments

Discussion

References

1.30 Pseudomyopia

Clinical Findings

Discussion

References

1.31 Comprehensive Color Vision Evaluation

Color Vision Testing

Hardy Rand and Rittler Pseudo isochromatic Test (Richmond Products, Albuquerque, New Mexico— 4th Edition)

Summary of results (see Figure 1.31-1)

24 Plate Ishihara Test (1971)

Summary of results (see Table 1.31-1)

Farnsworth D15 Test

Summary of results (see Figure 1.31-2)

Lanthony D15 Test

Summary of results (see Figure 1.31-3)

Anomaloscope

Summary of results

Farnsworth-Munsell 100 Hue Test

Summary of results (see Figure 1.31-4)

Discussion

References

1.32 Color Vision Occupational Questions

Color Vision Testing

Hardy Rand and Rittler Pseudoisochromatic Test (Richmond Products, Albuquerque, New Mexico— 4th Edition)

Summary of results (see Figure 1.32-2)

24 Plate Ishihara test (1971)

Summary of results (see Table 1.32-1)

Farnsworth D15

Summary of results (see Figure 1.32-1B)

Anomaloscope (Oculus, HMC)

Discussion

References

1.33 Hereditary Color Vision Deficiency in a Young Child

Color Vision Assessment

Cone Contrast Test

Discussion

Disclosure

References

1.34 Acquired Color Vision Deficiency

Clinical Findings

Discussion

References

1.35 Infant Hyperopia

Clinical Findings

Follow-up Visit (1 Week Following the Initial Examination)

Discussion

References

1.36 High Refraction in Infancy

Clinical Findings

Internal Ocular Examination (After 20 Minutes)

Management and Discussion

Follow-up Visit 4 Months Later (10 Months Old)

Discussion

Follow-up

References

1.37 Down Syndrome

First Visit

Clinical Findings

Comments

Discussion

Conflict of Interest

References

1.38 Retinoblastoma

Clinical Findings

Comments

Discussion

References

Section 2: Anterior Segment

2.1 Use of Gas Permeable Versus Soft Contact Lenses

Clinical Findings

Discussion

References

2.2 Monovision Contact Lenses

Clinical Findings

Comments

Discussion

References

2.3 Multifocal Gas Permeable Contact Lenses

Clinical Findings

Comments

Discussion

References

2.4 Management of Keratoconus With Gas Permeable Contact Lenses

Clinical Findings

Comments

Discussion

References

2.5 Contact Lens Noncompliance: Medico-legal

Clinical Findings

Comments

Discussion

References

2.6 Contact Lens Noncompliance: Therapeutic

Clinical Findings

Discussion

References

2.7 Hordeolum

Clinical Findings

Comments

Comments

Discussion

References

2.8 Chalazia

Clinical Findings

Comments

Discussion

References

2.9 Blepharitis

Clinical Findings

Comments

Discussion

References

2.10 Ectropion

Clinical Findings

Comments

Discussion

References

2.11 Blepharospasm

Clinical Findings

Comments

Discussion

References

2.12 Dacryocystitis

Clinical Findings

Comments

Discussion

References

2.13 Dry Eye Disease

Clinical Findings

Comments

Discussion

References

2.14 Dry Eye Disease Associated With Secondary Sjӧgren Syndrome

Clinical Findings

Comments

Discussion

References

2.15 Preseptal Cellulitis

Clinical Findings

Comments

Discussion

References

2.16 Papilloma

Clinical Findings

Comments

Discussion

References

2.17 Molluscum Contagiosum

Clinical Findings

Comments

Discussion

References

2.18 Adult Inclusion Conjunctivitis

Clinical Findings

Comments

Discussion

References

2.19 Epidemic Keratoconjunctivitis

Clinical Findings

Comments

Discussion

References

2.20 Vernal Keratoconjunctivitis

Clinical Findings

Discussion

References

2.21 Giant Papillary Conjunctivitis

Clinical Findings

Comments

Discussion

References

2.22 Ocular Rosacea

Clinical Findings

Comments

Discussion

References

2.23 Childhood Ocular Rosacea

Clinical Findings

Comments

Discussion

References

2.24 Phlyctenule

Clinical Findings

Comments

Discussion

References

2.25 Conjunctival Cysts

Clinical Findings

Comments

Discussion

References

2.26 Subconjunctival Hemorrhage

Clinical Findings

Comments

Discussion

References

2.27 Pinguecula

Clinical Findings

Comments

Discussion

References

2.28 Pterygium

Clinical Findings

Comments

Discussion

References

2.29 Herpes Simplex Keratitis

Clinical Findings

Comments

Discussion

References

2.30 Peripheral Corneal Ulcer

Clinical Findings

Comments

Discussion

References

2.31 Recurrent Corneal Erosion

Clinical Findings

Comments

Discussion

References

2.32 Ocular Effects of Amiodarone

Clinical Findings

Discussion

References

2.33 Cataract

Clinical Findings

Discussion

References

2.34 Toric Multifocal Intraocular Lenses

Clinical Findings

Comments

Discussion

References

2.35 Multifocal Intraocular Lenses

Clinical Findings

Comments

Discussion

References

2.36 Lens Subluxation

Clinical Findings

Comments

Discussion

References

2.37 Episcleritis

Clinical Findings

Comments

Discussion

References

2.38 Herpetic Anterior Uveitis

Clinical Findings

Comments

Comments

Discussion

References

2.39 Toxoplasmosis

Clinical Findings

Comments

Discussion

References

2.40 Sarcoidosis

Clinical Findings

Comments

Discussion

References

2.41 Iris Melanoma

Clinical Findings

Comments

Discussion

References

2.42 Ciliary Body Melanoma

Clinical Findings

Comments

Discussion

Acknowledgment

References

Section 3: Posterior Segment, Neuro-Ophthalmic, and Systemic Conditions

3.1 Dry Age-Related Macular Degeneration

Clinical Findings

Discussion

References

3.2 Wet Age-Related Macular Degeneration

Clinical Findings

Discussion

References

3.3 Diabetic Retinopathy

Clinical Findings

Comments

Discussion

Diabetic Macular Edema Management

Proliferative Diabetic Retinopathy Management

References

3.4 Cystoid Macular Edema

Clinical Findings

Comments

Follow-up Visits (2 and 6 Weeks Following the Initial Examination)

Discussion

References

3.5 Central Serous Retinopathy

Clinical Findings

Follow-up Visits (4 Weeks, 3 Months, and 6 Months Following the Initial Examination)

Discussion

References

3.6 Hydroxychloroquine Retinopathy

Clinical Findings

Discussion

References

3.7 Vitreomacular Traction

Clinical Findings

Comments

Follow-up Visit (3 Months Following the Initial Examination)

Discussion

References

3.8 Angioid Streaks

Clinical Findings

Discussion

References

3.9 Retinitis Pigmentosa

Clinical Findings

Follow-up Visit and Supplementary Testing (1 Week Following the Initial Examination)

Discussion

References

3.10 Retinal Vein Occlusion

Clinical Findings

Discussion

References

3.11 Retinal Artery Occlusion

Clinical Findings

Comments

Discussion

References

3.12 Peripheral Retinal Lesions

Clinical Findings

Discussion

Lattice Degeneration

Retinal Tufts

Atrophic Holes

Operculated Retinal Break

References

3.13 Rhegmatogenous Retinal Detachment

Clinical Findings

Comments

Discussion

References

3.14 Horner Syndrome

Clinical Findings

Comments

Discussion

References

3.15 Tonic Pupil

Clinical Findings

Discussion

References

3.16 Light– Near Disassociation

Clinical Findings

Discussion

References

3.17 Optic Nerve Drusen

Clinical Findings

Discussion

References

3.18 Demyelinating Optic Neuritis

Clinical Findings

Comments

Follow-up Visit (1 Month Following the Initial Examination)

Discussion

References

3.19 Nonarteritic Anterior Ischemic Optic Neuropathy

Clinical Findings

Discussion

References

3.20 Idiopathic Intracranial Hypertension

Clinical Findings

Comments

Discussion

References

3.21 Minocycline-Induced Pseudotumor Cerebri

Clinical Findings

Discussion

References

3.22 Pituitary Adenoma

Clinical Findings

Comments

Follow-up Visit (5 Weeks Following the Initial Examination)

Discussion

References

3.23 Cranial Nerve III Palsy

Clinical Findings

Comments

Follow-up Visit (1 Day Following the Initial Examination)

Discussion

References

3.24 Cranial Nerve IV Palsy

Clinical Findings

Discussion

References

3.25 Cranial Nerve VI Palsy

Clinical Findings

Comments

Follow-up Visit (1 Month Following the Initial Examination)

Comments

Discussion

References

3.26 Internuclear Ophthalmoplegia

Clinical Findings

Discussion

References

3.27 Intracranial Tumor

Clinical Findings

Discussion

References

3.28 Pansinusitis

Clinical Findings

Discussion

References

3.29 Nonorganic Vision Loss

Clinical Findings

Comments

Comments

Discussion

References

3.30 Primary Open Angle Glaucoma

Clinical Findings

Discussion

References

3.31 Pseudoexfoliation Glaucoma

Clinical Findings

Comments

Follow-up Visits and Supplemental Testing (6 Weeks Following the Initial Examination)

Comments

Discussion

References

3.32 Angle Closure Glaucoma

Clinical Findings

Comments

Follow-up Visit (3 Days Following the Initial Examination)

Comments

Follow-up Visit (2 Weeks Following the Initial Examination)

Discussion

References

3.33 Corneal Foreign Body

Clinical Findings

Discussion

References

3.34 Ocular Trauma

Clinical Findings

Comments

Follow-up Visits (2 Days, 1 Week, 2 Weeks, and 1 Month Following the Initial Examination)

Discussion

References

3.35 Ocular Effects of Hypertension

Clinical Findings

Comments

Follow-up Visit (1 Week Following the Initial Examination)

Discussion

References

3.36 Sarcoid Optic Neuropathy

Clinical Findings

Comments

Discussion

References

3.37 Ocular Toxoplasmosis

Clinical Findings

Comments

Follow-up Visit (4 Weeks Following the Initial Examination)

Discussion

References

3.38 Thyroid Eye Disease

Clinical Findings

Discussion

References

3.39 Myasthenia Gravis

Clinical Findings

Comments

Follow-up Visit (2 Weeks Following the Initial Examination):

Discussion

References

3.40 Acute Leukemia With Roth Spots

Clinical Findings

Comments

Follow-up Visit With Retinal Specialist (1 Day Following the Initial Examination)

Comments

Follow-up Visit With Retinal Specialist (1 Week Following the Initial Examination)

Comments

Discussion

Acknowledgment

References

3.41 Ocular Lymphoma

Clinical Findings

Comments

Discussion

References

3.42 Human Immunodeficiency Virus Retinopathy

Clinical Findings

Comments

Follow-up Visits (at 8 and 16 Weeks Following the Initial Examination)

Follow-up Visit (24 Weeks Following the Initial Examination)

Discussion

References

Index

 

An aparitie	2 Oct. 2018
Autor	Dr. Mark Rosenfield, Denise Goodwin, Eunice Myung Lee
Dimensiuni	17.78 x 2.03 x 25.4 cm
Editura	LWW
Format	Paperback
ISBN	9781496385345
Limba	Engleza
Nr pag	408
Versiune digitala	DA